Verdicts genuinely change. Free email alert the moment RSPH's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Invesco S&P 500 Equal Weight Health Care ETF ETF · Invesco Exchange-Traded Fund Trust
63 holdings · as of 2026-07-31 (2.4 months ago)
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 102% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 37.12% of portfolio weight is in non-compliant holdings, over the 5% threshold.
63 holdings, 60 matched (98% of weight). Portfolio as of 2026-07-31, filed 2026-09-28. Source: SEC Form N-PORT.
1.11% of this portfolio’s income is non-permissible — weighted across holdings, computed over 88% of portfolio weight (54 of 63 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
61.4% compliant 0.0% questionable 36.3% non-compliant 2.3% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| TECH Bio-Techne Corp. | COMPLIANT | 2.13% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| IQV IQVIA Holdings Inc. | NON_COMPLIANT | 2.00% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| BAX Baxter International Inc. | NON_COMPLIANT | 1.99% | AAOIFI1.7% Usmani1.1% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic1.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| REGN Regeneron Pharmaceuticals, Inc. | COMPLIANT | 1.96% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| MTD Mettler-Toledo International Inc. | COMPLIANT | 1.94% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| CRL Charles River Laboratories International, Inc. | COMPLIANT | 1.93% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VEEV Veeva Systems Inc. | NON_COMPLIANT | 1.93% | AAOIFI0.4% Usmani1.7% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.7% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| DVA DaVita Inc. | NON_COMPLIANT | 1.87% | AAOIFI119.4% Usmani75.7% Dow Jones Islamic119.5% S&P Shariah122.0% MSCI Islamic75.7% MSCI Islamic M-Series122.0% FTSE Shariah60.9% |
| MRNA Moderna, Inc. | NON_COMPLIANT | 1.85% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| TMO Thermo Fisher Scientific Inc. | COMPLIANT | 1.84% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| ABT Abbott Laboratories | COMPLIANT | 1.83% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| BMY Bristol-Myers Squibb Co. | NON_COMPLIANT | 1.82% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| UHS Universal Health Services, Inc. | NON_COMPLIANT | 1.80% | AAOIFI52.8% Usmani33.0% Dow Jones Islamic45.9% S&P Shariah48.2% MSCI Islamic33.0% MSCI Islamic M-Series48.2% FTSE Shariah30.4% |
| LH Labcorp Holdings Inc. | COMPLIANT | 1.78% | AAOIFI25.4% Usmani36.5% Dow Jones Islamic31.6% S&P Shariah33.5% MSCI Islamic36.2% MSCI Islamic M-Series33.5% FTSE Shariah31.6% |
| DGX Quest Diagnostics Inc. | COMPLIANT | 1.77% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| AMGN Amgen Inc. | COMPLIANT | 1.77% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| INCY Incyte Corp. | COMPLIANT | 1.76% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| BDX Becton, Dickinson and Co. | NON_COMPLIANT | 1.73% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| DXCM DexCom, Inc. | COMPLIANT | 1.73% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| ABBV AbbVie Inc. | COMPLIANT | 1.73% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| VTRS Viatris Inc. | NON_COMPLIANT | 1.72% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| RVTY Revvity, Inc. | COMPLIANT | 1.72% | AAOIFI23.1% Usmani27.9% Dow Jones Islamic27.9% S&P Shariah27.2% MSCI Islamic27.9% MSCI Islamic M-Series27.2% FTSE Shariah26.7% |
| COR Cencora, Inc. | COMPLIANT | 1.71% | AAOIFI18.9% Usmani14.0% Dow Jones Islamic20.8% S&P Shariah22.7% MSCI Islamic14.0% MSCI Islamic M-Series22.7% FTSE Shariah14.0% |
| STE Steris PLC | COMPLIANT | 1.70% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| PODD Insulet Corp. | COMPLIANT | 1.70% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| MRK Merck & Co., Inc. | COMPLIANT | 1.69% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| VRTX Vertex Pharmaceuticals Inc. | COMPLIANT | 1.69% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| RMD ResMed Inc. | COMPLIANT | 1.69% | AAOIFI2.6% Usmani9.2% Dow Jones Islamic2.4% S&P Shariah2.6% MSCI Islamic9.2% MSCI Islamic M-Series2.6% FTSE Shariah7.4% |
| HSIC Henry Schein, Inc. | NON_COMPLIANT | 1.68% | AAOIFI36.7% Usmani32.3% Dow Jones Islamic41.6% S&P Shariah41.0% MSCI Islamic32.3% MSCI Islamic M-Series41.0% FTSE Shariah29.2% |
| MCK McKesson Corp. | COMPLIANT | 1.68% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| JNJ Johnson & Johnson | COMPLIANT | 1.67% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| HCA HCA Healthcare, Inc. | NON_COMPLIANT | 1.67% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| Invesco Private Prime Fund | UNSCREENED | 1.66% | no in-house ratios for this holding |
| GILD Gilead Sciences, Inc. | COMPLIANT | 1.66% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| COO Cooper Cos., Inc. (The) | COMPLIANT | 1.65% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GEHC GE HealthCare Technologies Inc. | NON_COMPLIANT | 1.65% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| CVS CVS Health Corp. | NON_COMPLIANT | 1.65% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| ZBH Zimmer Biomet Holdings, Inc. | NON_COMPLIANT | 1.65% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| MDT Medtronic PLC | COMPLIANT | 1.65% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| CAH Cardinal Health, Inc. | COMPLIANT | 1.65% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| DHR Danaher Corp. | COMPLIANT | 1.64% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| SOLV Solventum Corp. | NON_COMPLIANT | 1.63% | AAOIFI32.5% Usmani37.1% Dow Jones Islamic39.6% S&P Shariah41.1% MSCI Islamic35.7% MSCI Islamic M-Series41.1% FTSE Shariah35.7% |
| SYK Stryker Corp. | COMPLIANT | 1.63% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| A Agilent Technologies, Inc. | COMPLIANT | 1.63% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| BIIB Biogen Inc. | COMPLIANT | 1.62% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| WAT Waters Corp. | COMPLIANT | 1.61% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| WST West Pharmaceutical Services, Inc. | COMPLIANT | 1.59% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| UNH UnitedHealth Group Inc. | NON_COMPLIANT | 1.57% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| LLY Eli Lilly and Co. | COMPLIANT | 1.57% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| IDXX IDEXX Laboratories, Inc. | COMPLIANT | 1.56% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| EW Edwards Lifesciences Corp. | COMPLIANT | 1.55% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| HUM Humana Inc. | NON_COMPLIANT | 1.55% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| ALGN Align Technology, Inc. | COMPLIANT | 1.54% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| PFE Pfizer Inc. | NON_COMPLIANT | 1.51% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| BSX Boston Scientific Corp. | COMPLIANT | 1.50% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| CNC Centene Corp. | NON_COMPLIANT | 1.47% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| ZTS Zoetis Inc. | NON_COMPLIANT | 1.47% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| CI Cigna Group (The) | NON_COMPLIANT | 1.46% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| ELV Elevance Health, Inc. | NON_COMPLIANT | 1.44% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| ISRG Intuitive Surgical, Inc. | COMPLIANT | 1.33% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| Invesco Private Government Fund | UNSCREENED | 0.59% | no in-house ratios for this holding |
| Invesco Government & Agency Portfolio | UNSCREENED | 0.05% | no in-house ratios for this holding |
| TPG TPG Inc. | NON_COMPLIANT | 0.00% | AAOIFI11.6% Usmani16.7% Dow Jones Islamic11.8% S&P Shariah13.1% MSCI Islamic16.7% MSCI Islamic M-Series13.1% FTSE Shariah16.7% |
The published standards disagree about this fund by 12 points of portfolio weight — 56.2% of it passes FTSE Shariah, 44.3% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 55.3% ratios fail on 32.2% 14.7% not rated under AAOIFI
ratios pass on 50.6% ratios fail on 36.9% 14.7% not rated under Usmani
ratios pass on 53.6% ratios fail on 33.9% 14.7% not rated under Dow Jones Islamic
ratios pass on 53.4% ratios fail on 34.1% 14.7% not rated under S&P Shariah
ratios pass on 44.3% ratios fail on 44.9% 13.0% not rated under MSCI Islamic
ratios pass on 51.8% ratios fail on 35.7% 14.7% not rated under MSCI Islamic M-Series
ratios pass on 56.2% ratios fail on 31.3% 14.7% not rated under FTSE Shariah
60 of 63 listed holdings carry our own per-methodology verdicts (100% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 54 (89% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| IQV IQVIA Holdings Inc. | 2.00% |
| BAX Baxter International Inc. | 1.99% |
| VEEV Veeva Systems Inc. | 1.93% |
| DVA DaVita Inc. | 1.87% |
| MRNA Moderna, Inc. | 1.85% |
| BMY Bristol-Myers Squibb Co. | 1.82% |
| UHS Universal Health Services, Inc. | 1.80% |
| BDX Becton, Dickinson and Co. | 1.73% |
| VTRS Viatris Inc. | 1.72% |
| HSIC Henry Schein, Inc. | 1.68% |
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
Computing the full ratio and business-activity breakdown for RSPH — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 59.40 | NEUTRAL |
| Stochastic %K (14) | 94.96 | SELL |
| CCI (20) | 124.55 | SELL |
| Williams %R (14) | -5.04 | SELL |
| MACD (12,26,9) | -0.01 | SELL |
| ROC (10) | 0.62 | BUY |
| Momentum (10) | 0.23 | BUY |
| EMA (10) | 37.10 | BUY |
| SMA (10) | 37.09 | BUY |
| EMA (20) | 37.01 | BUY |
| SMA (20) | 36.99 | BUY |
| EMA (30) | 36.86 | BUY |
| SMA (30) | 36.99 | BUY |
| EMA (50) | 36.37 | BUY |
| SMA (50) | 36.71 | BUY |
| EMA (100) | 35.13 | BUY |
| SMA (100) | 34.67 | BUY |
| EMA (200) | 33.64 | BUY |
| SMA (200) | 33.05 | BUY |
The underlying index, which is composed of securities of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (“GICS®”). The fund generally invests in all of the securities comprising the underlying index in proportion to their weightings in the underlying index.
Background via Yahoo Finance — informational, not part of the verdict.
Good setup, solid confluence
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 41 |
| ⏰ 4H | BULLISH | 24 |
| 🕐 1H | BULLISH | 97 |
| ⏱ 15-Min | BULLISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-06 · Asset managers net 906615 (+2612)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.